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Abstract A cDNA was cloned and expressed that encodes 
human stress-activated protein kinase kinase-4 (SKK4), a novel 
MAP kinase kinase family member whose mRNA is widely 
expressed in human tissues. SKK4 activated SAPK1/JNK in 
vitro, but not SAPK2a/p38, SAPK2b/p38p\ SAPK3/ERK6 or 
SAPK4. It appears to be the mammalian homologue of HEP, an 
activator of SAPK1/JNK in Dvosophila. In human epithelial KB 
cells SKK4 and SKK1/MKK4 (another activator of SAPK1/ 
JNK) were both activated by stressful stimuli, but only SKK4 
was activated by proinflammatory cytokines. The identification 
of SKK4 explains why the major SAPK1/JNK activator detected 
in many mammalian cell extracts is chromatographically 
separable from SKK1/MKK4. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Seven mitogen-activated protein kinase (MAPK) family 
members have been identified that are activated strongly by 
adverse stimuli (e.g. chemical, heat and osmotic shock, ultra-
violet radiation and the protein synthesis inhibitor anisomy-
cin) or by signals produced/released during infection (e.g. lipo-
polysaccharide and the proinflammatory cytokines inter-
leukin-1 (IL-1) and tumour necrosis factor (TNF)), but only 
weakly (in most cell contexts) by polypeptide growth factors 
or phorbol esters (reviewed in [1]). For these reasons, they are 
termed stress-activated protein kinases (SAPKs). 
The three isoforms of SAPK1/JNK bind tightly to the acti-
vation domain of c-Jun and are the only SAPKs that phos-
phorylate (at significant rates) the residues in this transcrip-
tion factor that become phosphorylated in vivo in response to 
adverse stimuli and proinflammatory cytokines [2-4]. The two 
isoforms of SAPK2/p38 (SAPK2a/p38 and SAPK2b/p38P) are 
inhibited specifically by the pyridinyl imidazoles SB 203580 
and SB 202190 at submicromolar concentrations [4-6] and 
their physiological substrates include the transcription factors 
Elkl [7], SAP1 [7], CHOP [8] and MEF2C [9], as well as 
MAPK-activated protein kinase-2 (MAPKAP-K2) [10], 
MAPKAP-K3 [11,12], MAPK-interacting protein kinase-1 
(Mnkl) and Mnk2 [13,14]. Intracellular targets for MAP-
KAP-K2/MAPKAP-K3 include heat shock protein 27 [5,15], 
tyrosine hydroxylase [16] and the transcription factor CREB 
[17], while one of the substrates for Mnkl/Mnk2 is eukaryotic 
initiation factor eIF4E [13]. SAPK3/ERK6 [18-20] and 
SAPK4 [4,6] have only been identified recently and their phys-
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iological substrates are unknown. SAPK3 and SAPK4 are 
60% identical to each other or to SAPK2a and SAPK2b, 
but they are not inhibited by SB 203580 and SB 202190 
[4,6,18]. 
The SAPKs are activated by MAPK kinase (MKK) family 
members, termed here SAPK kinases (SKKs). The major ac-
tivator of SAPK2a/p38, SAPK2b/p38p, SAPK3 and SAPK4 
that has been detected biochemically is SKK3/MKK6 
[4,18,21-23], although SAPK2/p38 can also be activated by 
SKK2/MKK3 in vitro [24]. Neither SKK2/MKK3 nor 
SKK3/MKK6 are capable of activating SAPK1/JNK, which 
is activated by a distinct enzyme termed SKK1/MKK4 
[24,25]. SKK1/MKK4 is the only activator of SAPK1/JNK 
that can be detected biochemically in extracts prepared from 
PC 12 cells that have been exposed to adverse stimuli [21], and 
in 293 cells the activation of transfected SAPK 1/JNK by ani-
somycin can be prevented by overexpressing a catalytically 
inactive form of SKK1/MKK4 [25]. In addition, heat shock 
or anisomycin failed to activate SAPK1/JNK in murine em-
bryonic stem cells lacking SKK1/MKK4 [26,27]. 
SKK1/MKK4 can activate SAPK2/p38 in vitro [24,28] but, 
in contrast to SAPK 1/JNK which is activated strongly by 
cotransfection with MEK kinase (MEKK) [29] (an upstream 
activator of SKK1/MKK4), SAPK2/p38 is not activated [24] 
or activated much more weakly [30]. Moreover the activation 
of SAPK2/p38 by osmotic shock and anisomycin is unim-
paired in murine embryonic stem cells lacking SKK1/MKK4 
[26,27]. For these reasons, SKK1/MKK4 does not seem to be 
rate-limiting for the activation of SAPK2/p38 in vivo. 
Although SKK1/MKK4 is clearly essential for the activa-
tion of SAPK1/JNK in some cells, the dominant activator of 
SAPK 1/JNK detected biochemically in extracts from human 
epithelial KB cells [21] or Rat 3Y1 fibroblasts [31] is a chro-
matographically distinct enzyme(s). Moreover, the activation 
of SAPK1/JNK by UV radiation and osmotic shock in mur-
ine embryonic stem cells lacking SKK1/MKK4 was either 
unimpaired [26] or only inhibited partially [27], These obser-
vations indicate that mammalian cells contain at least one 
further activator of SAPK1/JNK distinct from SKK1/ 
MKK4. In this paper we have cloned a novel MKK family 
member, termed here SKK4, that is activated by stressful 
stimuli and proinflammatory cytokines and which activates 
SAPK1/JNK, but not other SAPKs. 
2. Materials and methods 
2.1. Materials 
An E. coli plasmid encoding a fusion protein comprising gluta-
thione S-transferase (GST) linked to residues 19-96 of activating tran-
scription factor-2 (GST-ATF2[19-96]) was provided by Dr. N. Jones 
(ICRF, London) and a plasmid encoding GST-SKK1/MKK4 by Dr. 
J. Woodgett (Ontario Cancer Institute, Toronto). A plasmid encoding 
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the maltose-binding protein (MalE) linked to the Xenopus homologue 
of SAPK2a/p38 (MalE-Mpk2) was a gift from Dr. A.R. Nebreda 
(EMBL, Heidelberg, Germany), while a plasmid encoding MEKK 
preceded by six histidine residues (6-His-MEKK) was provided by 
Dr. G. Johnson (National Jewish Centre for Immunology and Respi-
ratory Medicine, Denver, USA). All plasmids were transformed into 
E. coli strain BL21 (DE3), and expressed and purified as described 
[4,18,21]. 6-His SAPKl/JNKly [32] was expressed and purified as 
reported previously [33]. PKI, the specific peptide inhibitor of 
cAMP-dependent protein kinase (TTYADFIASGRTGRRNAIHD) 
was synthesised by Mr. F.B. Caudwell in the MRC Protein Phospho-
rylation Unit in Dundee and other peptides by Dr. Graham Bloom-
berg, University of Bristol, UK. 
2.2. cDNA cloning and sequencing 
Two oligonucleotides corresponding to part of the EST encoded by 
GenBank ID H85962, (forward, 5'-GACGGATCCGACCCCAC-
CAAGCCGGACTTT; reverse, 5'-GGCCAAGCTTGTCTTTGAC-
GAAGGACTGGAA) were used to amplify a 209-bp fragment from 
a XgtlO human skeletal muscle cDNA library (Clontech). The nucleo-
tide sequence of this product was identical to that in the database. 
The PCR fragment was 32P-labelled by random priming and used to 
probe the same cDNA library at high stringency. One strongly hybrid-
ising plaque was identified after screening 500000 plaques. This clone 
was isolated, the phage DNA purified, and the insert cloned into 
pBluescript (Stratagene) and sequenced using an Applied Biosystems 
model 373A DNA sequencer. 
2.3. Expression of GST-SKK4 in E. coli 
The open reading frame of SKK4 was amplified by PCR and sub-
cloned as a BamHI/EcoRl fragment into the expression vector 
pGEX4T-3 (Pharmacia) followed by transformation into E. coli strain 
BL21 (DE3). Expression and purification of GST-SKK4 were carried 
out as described in [34]. The purified protein was dialysed against 50 
mM Tris/HCl pH 7.5, 0.1 mM EGTA, 0.03% (m/v) Brij35, 0.1% (v/v) 
2-mercaptoethanol and 50% (v/v) glycerol, and stored unfrozen at 
-20°C at 2 mg/ml. 
0.125 mM EGTA, 1.25 mM sodium orthovanadate, 3.1 uM PKI, 
0.1% (by vol.) 2-mercaptoethanol and 0.25 mg/ml GST-ATF2[19-
96], 12.5 mM magnesium acetate and 0.125 mM [y-32P]ATP. After 
30 min at 30°C reactions were stopped by adding 5 ixl of 6% (m/v) 
SDS, 400 mM Tris/HCl (pH 6.8), 50% (v/v) glycerol, 5% (v/v) 2-
mercaptoethanol and 0.2% (m/v) bromophenol blue. A 40 |xl aliquot 
was withdrawn, electrophoresed on a 10% SDS/polyacrylamide gel 
and autoradiographed. The 32P-labelled band corresponding to 
GST-ATF2[19-96] was excised and counted. One unit of SKK1/ 
MKK4 or SKK4 activity was that amount which increased the activ-
ity of SAPK1/JNK by 1 U/min. One Unit of SAPK1/JNK was that 
amount which incorporated 1 nmol of phosphate into GST-ATF2[19-
96] in one min. 
SKK1/MKK4 and SKK4 were also assayed for their ability to 
activate Xenopus SAPK2a. The assay was identical except that SAP-
K2a (2 uM) replaced SAPK1/JNK. 
2.8. Activation and assay of expressed GST-SKK4 and 
GST-SKK1IMKK4 
Each GST fusion protein (4 u,M) was activated by incubation for 60 
min at 30°C with MEKK (1 uM) in 50 mM Tris/HCl pH 7.5, 0.1 mM 
EGTA, 0.1% (v/v) 2-mercaptoethanol, 10 mM magnesium acetate and 
0.1 mM unlabelled ATP. Activated GST-SKK4 and GST-SKK1/ 
MKK4 were then measured by their ability to activate SAPK1/JNK 
or SAPK2a/p38, which were assayed by the phosphorylation of 
ATF2. The assays (50 \i\) were carried out at 30°C and comprised 
0.1 u.M GST-SKK4 or GST-SKK1/MKK4, 0.2 11M 6-His SAPK1/ 
JNK, 0.2 mg/ml GST-ATF2[19-96], 50 mM Tris/HCl pH 7.5, 0.1 
mM EGTA, 0.1% (v/v) 2-mercaptoethanol, 10 mM magnesium ace-
TGCTCCTGCGCGGTCCGAACGAGCAGCCCTGCAGCTCCCGCTGGCCAACGATGGGGGCAG 
CCGCTCGCCATCCTCAGAGAGCTCCCCGCAGCACCCCACGCCCCCCGCCCGGCCCCGCCA 
M E S I E T D 
CATGCTGGGGGTGCCGTGAAGGGTGTTCACACGCGGCAGGATGGAGAGCATTGAGATTGA 
Q K L Q E I M K Q T G Y L T I G G Q R Y 
GCAGAAGCTGGAGGAGATCATGAAGCAGACGGGCTACCTGACCATCGGGGGCCAGCGCTA 
2.4. Preparation of anti-SKK4 and anti-SKKlIMKK4 antibodies 
Peptides were synthesised corresponding to the C-terminal 12 resi-
dues of human SKK 4 (GVLSQPHLPFFR) and the last 14 residues 
of SKK1/MKK4 (DQMPATPSSPMYVD) [24], coupled to both bo-
vine serum albumin and keyhole limpet haemocyanin using glutaral-
dehyde and injected into sheep at the Scottish Antibody Production 
Unit (Carluke, Ayrshire, UK). The anti-SKK4 and anti-SKKl/ 
MKK4 antibodies were purified on peptide antigen-CH-Sepharose 
columns [22]. 
CCAGGCAGAAATCAACGACCTGGAGAAGTTGGGGGAGATGGGCAGCGGCACCTGCGGCCA 
GGTGTGGAAGATGCGCTTCCGGAAGACCGGCCACGTCATTGCCGTTAAGCAAATGCGGCG 
S G N K E E N K R I L M D L D V V L K S 
CTCGGGGAACAAGGAGGAGAACAAGCGCATCCTCATGGACCTGGATGTGGTGCTGAAGAG 
CCACGACTGCCCCTACATCGTGCAGTGCTTTGGGACGTTCATGACCAACACGGACGTCTT 
CATCGCCATGGAGGTGATGGGGACGTGCGCTGAGAAGCTCAAGAAGCGGATGCAGGGCCC 
2.5. Cell culture and cell lysis 
KB cells were cultured [18] and exposed for 15 min to osmotic stress 
(0.5 M sorbitol) or proinflammatory cytokines (20 ng/ml IL-la or 100 
ng/ml TNFoc), or for 30 min to anisomycin (10 ug/ml), or for 10 min 
to 100 ng/ml epidermal growth factor (EGF) or 300 ng/ml phorbol 
myristate acetate (PMA). UV-C irradiation was carried out at 60 J/m2 
and the cells then incubated for a further 30 min at 37°C. Cells were 
lysed as described [21]. 
2.6. Immunoprecipitation of SKK4 and SKK1/MKK4 
KB cell lysates (250 ug) were incubated for 60 min at 4°C with 10 
|xg of affinity purified antibody coupled to 5 |xl protein G-Sepharose. 
The protein G-Sepharose immunoprecipitates were washed twice with 
1 ml lysis buffer containing 0.5 M NaCl, twice with lysis buffer with-
out NaCl and assayed as described below. In control experiments, 
antibodies bound to protein G-Sepharose were incubated for 30 min 
at 4°C with the peptide immunogen (1 mg/ml) prior to the addition of 
cell lysate. 
2.7. Assay of SKK1/MKK4 and SKK4 immunoprecipitates 
Immunoprecipitates (~6.5 ul) were incubated on a shaking plat-
form for 30 min at 30°C with 1 u] of 20 uM 6-His-SAPKl/JNK in 50 
mM Tris/HCl (pH 7.4), 0.1 mM EGTA, 0.03% (m/v) Brij-35, 0.1% (v/ 
v) 2-mercaptoethanol and 5% (v/v) glycerol, and the reactions ini-
tiated with 2.5 ul of 40 mM magnesium acetate-0.4 mM unlabelled 
ATP. After 30 min, the active SAPK1/JNK generated was assayed by 
adding 40 ul of a solution containing 31.25 mM Tris/HCl (pH 7.4), 
I P E R I L G K M T V A I V K A L Y Y L 
CATCGCGGAGCGGATTCTGGGCAAGATGACAGTGGCGATTGTGAAGGCGCTGTACTACCT 
GAAGGAGAAGCACGGTGTGATCCACCGCGACGTCAAGCCCTCCAACATCCTGCTGGACGA 
GCGGGGCCAGATCAAGCTCTGCGACTTCGGCATCAGCGGCCGCCTGGTGGACTCCAAAGC 
CAAGACGCGGAGCGCCGGGTGTGGCGCGTACATGGCAGGCGAGCGCATTGACCCCCCAGA 
GCCCACCAAGCCGGACTATGACATCCGGGCCGACGTATGGAGCCTGGGCATCTCGTTGGT 
E L A T G Q F P Y K N C K T D F E V L T 
GGAGCTGGCAACAGGAGAGTTTCGCTACAAGAACTGCAAGACGGACTTTGAGGTGGTGAG 
CAAAGTCCTACAGGAAGAGCCCCCGCTTCTGCCCGGACACATGGGCTTCTCGGGGGACTT 
Q S F V K D C L T K D H R K R P K Y N K 
CCAGTCCTTCGTCAAAGACTGCCTTACTAAAGATCACAGGAAGAGACCAAAGTATAATAA 
GC'l'ACTTGAACACAGCTTCATCAAGCGCTACGAGACGCTGGAGGTGGACGTGGCGTCCGG 
GTTCAAGGATGTCATGGCGAAGACTGAGTCACCGGGGACTAGCGGCGTCCTGAGCCAGGC 
GCACGTGCGCTTGTTCAGGTAGCTGCTTGGGGGCGGCCAGCCCGACAGGGGGGCAGGGGC 1200 
Fig. 1. Nucleotide and predicted amino acid sequence of human 
SKK4. Nucleotides are numbered in the 5' to 3' direction and ami-
no acids are shown in single-letter code above the nucleotide se-
quence. The in-frame termination codon is marked with an asterisk. 
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tate and 0.1 mM [T 3 2 P]ATP. The reactions were terminated by spot-
ting 40 ill on to 2X2 cm squares of phosphocellulose p81 paper 
followed by immersion into 75 mM phosphoric acid. After washing 
the papers several times in phosphoric acid, followed by immersion in 
acetone, the papers were dried and counted. 
3. Results 
3.1. Molecular cloning of SKK4 
To identify novel members of the SKK family, we used the 
DNA sequence encoding SKK1/MKK4 to interrogate a num-
ber of EST databases. This search identified a 250-bp se-
quence (GenBank ID H85962) that was distinct from any 
previously identified SKK homologue, but was much more 
closely related to members of this family than to any other 
protein kinase. A suitable PCR probe (see the Methods in 
Section 2) was therefore used to screen a human skeletal 
muscle cDNA library. This resulted in the isolation of a 1.2-
kbp clone that encoded a novel MKK family member, here-
after termed SKK4. The nucleotide and deduced amino acid 
sequence of human SKK4 is shown in Fig. 1. The open read-
ing frame encodes a protein of 333 residues, with a predicted 
molecular mass of 37.9 kDa. It possesses all the conserved 
amino acid domains (I-XI) characteristic of protein kinases 
and shows 62% identity with the Drosophila MKK homologue 
HEP (see Section 4), 48% identity with human SKK1/MKK4, 
39% identity with human SKK2/MKK3, and 41% identity 
with human SKK3/MKK6 (Fig. 2). The sequence identity 
with MKK1 and MKK2 is 36% and 35%, respectively. 
Ser185 and Thr189 in kinase subdomain VIII are in an equiv-
alent position to the Ser/Thr residues in other MKK family 
members, whose phosphorylation is required to generate en-
zymatic activity.Hybridisation of 32P-labelled SKK4 cDNA to 
multiple tissue Northern blots (Clontech) showed an RNA 
transcript of ~ 4 kbp that was present in heart, brain, placen-
ta, lung, liver, skeletal muscle, kidney and pancreas (data not 
shown). The presence of ESTs in databases revealed that 
SKK4 is also expressed in retina and germinal centre B-cells. 
Thus SKK4 mRNA is widely expressed in mammalian cells. 
3.2. SKK4 is activated by proinfiammatory cytokines and 
stressful stimuli 
An antibody was raised against the unique C-terminal se-
quence of SKK4 (Section 2.4) and used to immunoprecipitate 
SKK4 from KB cell extracts after stimulation with a variety 
of agonists (Fig. 3). These studies revealed that SKK4 was 
activated rapidly in KB cells in response to the same stimuli 
that trigger the activation of SAPK1/JNK [21], namely proin-
fiammatory cytokines and stressful stimuli (UV radiation, os-
motic shock and anisomycin). SKK4 was activated weakly by 
EGF, but not by PMA. SKK4 was also activated by stressful 
stimuli in COS cells (data not shown). SKK4 was activated to 
a greater extent by interleukin-1 (IL-1) and tumour necrosis 
factor (TNFa) than by UV irradiation, osmotic shock or ani-
somycin. 
SKK1/MKK4, another activator of SAPK1/JNK (see In-
troduction) is also present in KB cells and, like SKK4, was 
activated by UV irradiation, osmotic shock and anisomycin. 
However, in contrast to SKK4, SKK1/MKK4 was hardly 
activated by interleukin-1, TNFa or EGF (Fig. 3A). 
The specificities of the antibodies used in these experiments 
were established by the finding that immunoprecipitation of 
! - « S SKK4 
94 RSPSASSSSSSRSAFRSAAPATCLRWTYTPPTTRVSRATPTLPMLSSOPGGDVECHPVISPIJTPPH^ HEP 
1 MAAPSPSGGGGSGGGEGSGTPGPVGSPAPGHPAVSSMQGKRKALKLNFMIPPFKSAARFRBNPNPTGVQN SKK1 
1 - - - - - - M S K | SKK2 
1 MSQSKGKKiNPGiKliKEAlllQ. SKK3 
4 I ^ D Q K L Q E f l M K Q l i Y ^ ^ - S R Y Q A i : 
164 VSETDHKLKaiMEQTGKLNIl^QYPTDI 
" " " 3SP: 
IVMAKTESPRT E GVLSQPHLPFFR 
IH0CGQWRENAPEVT 
iQMPATPS IPMYVD 
'Is 
SKK4 
HEP 
SKK1 
SKK2 
SKK3 
Fig. 2. Sequence comparison of human SKK4, Drosophila JNKK (HEP), human SKK1/MKK4, human SKK2/MKK3 and human SKK3/ 
MKK6 [24,39]. Amino acids were aligned using the CLUSTAL program. Amino acid identities are shown by filled bars and asterisks denote 
the putative phosphorylation sites in the activation domain. Residues 94-487 of HEP are shown. 
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B 
1 
SKK4 pcptidc - -
SKKlpeptide - - - - + + 
Fig. 3. Activation of SKK4 and SKK1/MKK4 in KB cells. (A) KB cells were incubated in the absence (control) or presence of the indicated 
agonists as described in Section 2.7. and SKK4 (open bars) and SKK1/MKK4 (filled bars) immunoprecipitated from the lysates and assayed 
for their ability to activate SAPK1/JNK1. The results are shown as means ± S.E.M. for six dishes of cells with each agonist (two separate ex-
periments). The basal activity of SKK4 and SKK1/MKK4 in unstimulated cells was 5.0 ± 0.4 mU/mg and 2.0 ± 0.2 mU/mg, respectively. Abbre-
viations: IL-1, interleukin-l; TNFa, tumour necrosis factor a; EGF, epidermal growth factor; PMA, phorbol myristate acetate. (B) SKK4 
and SKK1/MKK4 were immunoprecipitated from extracts prepared from UV-irradiated KB cells. Where indicated, the antibodies were incu-
bated with the peptides used to raise the anti-SKK4 or anti-SKKl/MKK4 antibodies. The results are presented as means ± S.E.M. for at least 
three experiments. 
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Fig. 4. GST-SKK4 is activated by MEKK and activates SAPKl/JNK, but not SAPK2a/p38. GST-SKK4 (0.25 uM) and GST-SKK1/MKK4 
(0.1 |0,M) were incubated with MgATP in the presence or absence of MEKK and then assayed for their ability to activate SAPKl/JNK (A) or 
SAPK2a/p38 (B) (Section 2.8). The activation of SAPKl/JNK and SAPK2a/p38 were monitored by the phosphorylation of GST-ATF2[19-96]. 
The results are presented as means ± S.E.M. for at least three experiments. 
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Fig. 5. SKK4 immunoprecipitated from extracts prepared from UV-
irradiated KB cells activates SAPK1/JNK, but not SAPK2a/p38. 
SKK4 and SKK1/MKK4 immunoprecipitates were incubated with 
MgATP and SAPK2a/p38 or SAPK1/JNK. At the end of the reac-
tion SAPK2a/p38 and SAPK1/JNK activity was then measured us-
ing ATF2 as substrate. The results are expressed as means ± S.E.M. 
for three experiments. 
SKK4 was prevented by incubating the anti-SKK4 antibody 
with the SKK4 peptide immunogen used to generate it, but 
not with the SKK1/MKK4 peptide immunogen. Conversely, 
immunoprecipitation of SKK1/MKK4 was prevented by in-
cubating the anti-SKKl/MKK4 antibody with the SKK1/ 
MKK4 peptide immunogen, but not the SKK4 peptide im-
munogen (Fig. 3B). 
3.3. Activation and substrate specificity of SKK4 
GST-SKK4 was expressed in E. coli (Section 2.3.) and 10 
mg of purified enzyme could be isolated from 500 ml of bac-
terial culture. The preparation showed a single protein-stain-
ing band with the predicted molecular mass of 64 kDa (data 
not shown). GST-SKK4 was inactive, but could be activated 
by incubation with MgATP and MEKK (Fig. 4), an enzyme 
that also activates SKK1/MKK4 [29]. The activated GST-
SKK4 was able to activate SAPK1/JNK in vitro, but not 
SAPK2a/p38 (Fig. 4), SAPK2b/p38|3, SAPK3/ERK6 or 
SAPK4 (data not shown). In contrast, activated GST-
SKK1/MKK4 activated SAPK2a/p38 as well as SAPK1/ 
JNK (Fig. 4). 
SKK4 and SKK1/MKK4 immunoprecipitated from the ly-
sates of UV-stimulated KB cells had the same specificity as 
the bacterially expressed enzymes. Thus SKK4 activated 
SAPK1/JNK but not SAPK2a/p38, while SKK1/MKK4 acti-
vated both enzymes (Fig. 5). 
4. Discussion 
In this paper we have cloned a novel MKK homologue that 
is activated strongly by proinflammatory cytokines and stress-
ful stimuli, and has therefore been termed SKK4. SKK4 ex-
pressed in E. coli and activated in vitro, or immunoprecipi-
tated from KB cell extracts activated SAPK1/JNK, but was 
unable to activate other SAPKs, suggesting that SAPK1/JNK 
may be a physiological substrate of SKK4. This view is re-
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inforced by the striking similarity between SKK4 and the 
Drosophila MKK homologue, termed HEP (Fig. 2). HEP 
was identified by genetic dissection of a signalling pathway 
that is required for dorsal closure during early embryonic 
development and shown to be situated 'upstream' of Droso-
phila JNK [35-37]. Thus HEP is almost certainly the enzyme 
responsible for activating JNK in Drosophila. The generation 
of mice lacking SKK4 will be needed to find out if SKK4 also 
plays an essential role in mammalian embryonic development. 
SKK4 is activated in vitro by MEKK (Fig. 4), one of many 
protein kinases [38] that have been shown to activate SKK1/ 
MKK4 in vitro and to trigger the activation of SAPK1/JNK 
in cotransfection experiments. These observations, and the 
finding that overexpression of inactive mutants of SKK1/ 
MKK4 prevent the activation of SAPK1/JNK by MEKK, 
other upstream activators and stressful stimuli [25,29,38], sug-
gested that SKK1/MKK4 mediates the activation of SAPK1/ 
JNK in vivo. However, since the inactive mutant of SKK1/ 
MKK4 probably exerts its dominant negative effect by bind-
ing to SAPK1/JNK, it remained possible that MEKK and 
other upstream activators trigger the activation of SAPK1/ 
JNK via another MKK homologue. This view was confirmed 
by biochemical experiments which show that the major acti-
vator^) of SAPK1/JNK in several cell extracts is chromato-
graphically separable from SKK1/MKK4 [21,31], and by the 
finding that UV radiation and osmotic shock can still trigger 
the activation of SAPK1/JNK in stem cells from mice that do 
not express SKK1/MKK4 [26,27]. The present work indicates 
that one of the additional SAPK1/JNK activators is likely to 
be SKK4. Whether mammalian cells express additional MKK 
homologues that activate SAPK1/JNK remains to be estab-
lished. 
The present work (Fig. 3) and our earlier biochemical stud-
ies [21] showed that SKK4 is activated strongly by proinflam-
matory cytokines as well as stressful stimuli in KB cells, 
whereas SKK1/MKK4 is activated by stress stimuli only. 
These observations suggest that SKK4 may be a more attrac-
tive target for an anti-inflammatory drug than SAPK1/JNK 
because inhibitors of SKK4 may prevent the activation of 
SAPK1/JNK by proinflammatory cytokines, without affecting 
the activation of SAPK1/JNK by other agents. 
Note added in proof. Cloning of murine SKK4 was recently 
reported by Tournier et al. [40] and MKK7 by these investi-
gators. 
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